Results 101 to 110 of about 705 (166)

Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine. [PDF]

ACS Med Chem Lett
Kargbo RB.
europepmc   +1 more source

Adverse events and safety concerns among university students who misused stimulants to increase academic performance. [PDF]

Einstein (Sao Paulo)
Moreira JE, Rodrigues MCL, Palhares CVT, Oliveira THC, Gonçalves GKN.   +4 more
europepmc   +1 more source

The Use of Amantadine in a Nontraumatic Disorder of Consciousness: A Case Report. [PDF]

Cureus
Hanna M, Chen J, Salama D.
europepmc   +1 more source

A Matter of National Security: The Limitations of Contemporary Bioethical and Public Health Approaches for Addressing Enhanced Warfighters. [PDF]

Cureus
Irfan B, Sirvent R.
europepmc   +1 more source

Intranasal Drug Delivery in Neuropharmacology: Advances in Brain-Targeted Therapies and Bioethical Challenges. [PDF]

Biomedicines
Damian SI, David SM, Nour M, Halitchi GL, Ciurlea SA, Stefanache A, Duma OO, Calin G, Spaiuc D.   +8 more
europepmc   +1 more source

Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and "Smart Drug" Use and Misuse. [PDF]

Biology (Basel)
Schifano F, Bonaccorso S, Arillotta D, Corkery JM, Floresta G, Papanti Pelletier GD, Guirguis A.   +6 more
europepmc   +1 more source

Can neurotechnology revolutionize cognitive enhancement? [PDF]

PLoS Biol
Violante IR, Okyere P.
europepmc   +1 more source

Advances in Glaucoma Diagnosis and Treatment: Integrating Innovations for Enhanced Patient Outcomes. [PDF]

Biomedicines
Hung SH, Yen WT, Lu DW.
europepmc   +1 more source

Current perspectives in tackling glaucoma blindness. [PDF]

Indian J Ophthalmol
Bhartiya S, Ichhpujani P, Wadhwani M.
europepmc   +1 more source

A Phase I Randomized Trial of Topical Insulin for Glaucoma: Safety and Efficacy Outcomes. [PDF]

Ophthalmol Sci
Saludares M, Wennberg-Smith Z, Beykin G, Khatib TZ, Nunez M, Wang Q, Di Polo A, Goldberg JL.   +7 more
europepmc   +1 more source